A Systematic Review and Meta‐analysis of Ketamine as an Alternative to Opioids for Acute Pain in the Emergency Department

Background Opioids are commonly prescribed in the emergency department (ED) for the treatment of acute pain. Analgesic alternatives are being explored in response to an epidemic of opioid misuse. Low‐dose ketamine (LDK) is one opioid alternative for the treatment of acute pain in the ED. Objectives...

Full description

Saved in:
Bibliographic Details
Published in:Academic emergency medicine 2018-10, Vol.25 (10), p.1086-1097
Main Authors: Karlow, Nicholas, Schlaepfer, Charles H., Stoll, Carolyn R. T., Doering, Michelle, Carpenter, Christopher R., Colditz, Graham A., Motov, Sergey, Miller, Joshua, Schwarz, Evan S., Miner, James
Format: Article
Language:English
Subjects:
Emergency medical care
Evidence-based medicine
Ketamine
Meta-analysis
Narcotics
Pain
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Opioids are commonly prescribed in the emergency department (ED) for the treatment of acute pain. Analgesic alternatives are being explored in response to an epidemic of opioid misuse. Low‐dose ketamine (LDK) is one opioid alternative for the treatment of acute pain in the ED. Objectives This systematic review and meta‐analysis sought to quantify whether LDK is an effective and safe opioid alternative for acute pain reduction in adults in the ED setting. (PROSPERO Registration Number CRD42017065303). Methods This was a systematic review of randomized controlled trials comparing intravenous opioids to LDK for relief of acute pain in the ED. Studies where the control group initially received opioids prior to ketamine were excluded. A research librarian designed the electronic search strategy. Changes in visual analog scale or numeric rating scale pain scales were analyzed to determine the relative effects of LDK and opioids in the treatment of acute pain. Results Three studies met the criteria for inclusion in this meta‐analysis. Compared to pain scale reduction with morphine, ketamine was not inferior (relative reduction = 0.42, 95% confidence interval = –0.70 to 1.54). No severe adverse events were reported in any study, but higher rates of nonsevere adverse events were observed with ketamine. Conclusions Ketamine is noninferior to morphine for the control of acute pain, indicating that ketamine can be considered as an alternative to opioids for ED short‐term pain control.
ISSN:1069-6563
1553-2712
DOI:10.1111/acem.13502